Biogen Inc Stock Operating Margin

BIIB Stock  USD 157.46  1.14  0.73%   
Biogen Inc fundamentals help investors to digest information that contributes to Biogen's financial success or failures. It also enables traders to predict the movement of Biogen Stock. The fundamental analysis module provides a way to measure Biogen's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biogen stock.
Last ReportedProjected for Next Year
Operating Profit Margin 0.21  0.22 
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Biogen Inc Company Operating Margin Analysis

Biogen's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Operating Margin

 = 

Operating Income

Revenue

X

100

More About Operating Margin | All Equity Analysis

Current Biogen Operating Margin

    
  0.21 %  
Most of Biogen's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biogen Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Biogen Operating Margin Driver Correlations

Understanding the fundamental principles of building solid financial models for Biogen is extremely important. It helps to project a fair market value of Biogen Stock properly, considering its historical fundamentals such as Operating Margin. Since Biogen's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Biogen's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Biogen's interrelated accounts and indicators.
0.940.850.990.960.960.930.590.890.3-0.80.40.890.89-0.37-0.920.850.260.81-0.950.45-0.080.5-0.18-0.19-0.38
0.940.680.940.90.820.870.70.790.18-0.850.30.740.81-0.21-0.880.70.460.63-0.820.32-0.110.32-0.21-0.05-0.46
0.850.680.830.820.910.730.540.710.22-0.560.250.960.72-0.3-0.690.760.00.91-0.910.28-0.150.4-0.04-0.34-0.46
0.990.940.830.940.940.930.610.830.28-0.730.340.890.84-0.3-0.910.830.350.82-0.940.38-0.040.42-0.22-0.1-0.41
0.960.90.820.940.930.880.530.90.18-0.740.350.860.89-0.37-0.910.870.240.79-0.890.41-0.190.51-0.27-0.18-0.37
0.960.820.910.940.930.910.440.890.37-0.690.450.940.87-0.47-0.880.90.090.9-0.980.51-0.050.6-0.14-0.28-0.28
0.930.870.730.930.880.910.350.850.53-0.760.340.860.85-0.35-0.920.820.30.82-0.940.350.220.41-0.350.05-0.13
0.590.70.540.610.530.440.350.32-0.35-0.53-0.060.460.340.2-0.440.250.360.31-0.450.01-0.45-0.080.11-0.24-0.82
0.890.790.710.830.90.890.850.320.25-0.710.520.750.88-0.58-0.850.860.120.7-0.840.52-0.140.61-0.27-0.21-0.2
0.30.180.220.280.180.370.53-0.350.25-0.360.270.360.39-0.27-0.420.3-0.170.45-0.460.170.770.3-0.010.10.58
-0.8-0.85-0.56-0.73-0.74-0.69-0.76-0.53-0.71-0.36-0.23-0.61-0.770.160.79-0.51-0.21-0.520.72-0.2-0.05-0.250.110.10.22
0.40.30.250.340.350.450.34-0.060.520.27-0.230.20.47-0.87-0.350.510.00.2-0.350.84-0.180.880.16-0.340.07
0.890.740.960.890.860.940.860.460.750.36-0.610.20.77-0.27-0.780.810.090.96-0.960.240.030.36-0.21-0.15-0.35
0.890.810.720.840.890.870.850.340.880.39-0.770.470.77-0.48-0.870.920.270.8-0.860.44-0.030.58-0.07-0.25-0.06
-0.37-0.21-0.3-0.3-0.37-0.47-0.350.2-0.58-0.270.16-0.87-0.27-0.480.31-0.580.12-0.30.37-0.760.21-0.87-0.030.3-0.13
-0.92-0.88-0.69-0.91-0.91-0.88-0.92-0.44-0.85-0.420.79-0.35-0.78-0.870.31-0.8-0.2-0.760.87-0.36-0.09-0.480.170.130.11
0.850.70.760.830.870.90.820.250.860.3-0.510.510.810.92-0.58-0.80.250.86-0.850.53-0.10.66-0.14-0.26-0.09
0.260.460.00.350.240.090.30.360.12-0.17-0.210.00.090.270.12-0.20.250.1-0.14-0.10.0-0.21-0.210.34-0.29
0.810.630.910.820.790.90.820.310.70.45-0.520.20.960.8-0.3-0.760.860.1-0.930.230.120.39-0.12-0.19-0.13
-0.95-0.82-0.91-0.94-0.89-0.98-0.94-0.45-0.84-0.460.72-0.35-0.96-0.860.370.87-0.85-0.14-0.93-0.38-0.1-0.460.180.150.26
0.450.320.280.380.410.510.350.010.520.17-0.20.840.240.44-0.76-0.360.53-0.10.23-0.38-0.240.90.11-0.410.02
-0.08-0.11-0.15-0.04-0.19-0.050.22-0.45-0.140.77-0.05-0.180.03-0.030.21-0.09-0.10.00.12-0.1-0.24-0.25-0.140.440.59
0.50.320.40.420.510.60.41-0.080.610.3-0.250.880.360.58-0.87-0.480.66-0.210.39-0.460.9-0.250.14-0.480.13
-0.18-0.21-0.04-0.22-0.27-0.14-0.350.11-0.27-0.010.110.16-0.21-0.07-0.030.17-0.14-0.21-0.120.180.11-0.140.14-0.790.13
-0.19-0.05-0.34-0.1-0.18-0.280.05-0.24-0.210.10.1-0.34-0.15-0.250.30.13-0.260.34-0.190.15-0.410.44-0.48-0.790.08
-0.38-0.46-0.46-0.41-0.37-0.28-0.13-0.82-0.20.580.220.07-0.35-0.06-0.130.11-0.09-0.29-0.130.260.020.590.130.130.08
Click cells to compare fundamentals
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition

Biogen Pretax Profit Margin

Pretax Profit Margin

0.14

At present, Biogen's Pretax Profit Margin is projected to increase slightly based on the last few years of reporting.
Based on the recorded statements, Biogen Inc has an Operating Margin of 0.2074%. This is 100.59% lower than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The operating margin for all United States stocks is 103.76% lower than that of the firm.

Biogen Operating Margin Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biogen's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biogen could also be used in its relative valuation, which is a method of valuing Biogen by comparing valuation metrics of similar companies.
Biogen is currently under evaluation in operating margin category among its peers.

Biogen ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Biogen's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Biogen's managers, analysts, and investors.
Environmental
Governance
Social

Biogen Fundamentals

About Biogen Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Biogen Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biogen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biogen Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Biogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biogen Inc Stock:
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biogen. If investors know Biogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.02)
Earnings Share
11.05
Revenue Per Share
66.122
Quarterly Revenue Growth
(0.03)
Return On Assets
0.0499
The market value of Biogen Inc is measured differently than its book value, which is the value of Biogen that is recorded on the company's balance sheet. Investors also form their own opinion of Biogen's value that differs from its market value or its book value, called intrinsic value, which is Biogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biogen's market value can be influenced by many factors that don't directly affect Biogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.